U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

Childhood Malignant Ovarian Germ Cell Tumor

MedGen UID:
164003
•Concept ID:
C0886483
•
Neoplastic Process

Definition

A malignant germ cell tumor in children arising from the ovary. It includes the dysgerminoma, yolk sac tumor, choriocarcinoma, embryonal carcinoma and immature teratoma. [from NCI]

Professional guidelines

PubMed

DICER1-associated Tumors in the Female Genital Tract: Molecular Basis, Clinicopathologic Features, and Differential Diagnosis.
Han LM, Weiel JJ, Longacre TA, Folkins AK
Adv Anat Pathol 2022 Sep 1;29(5):297-308. Epub 2022 Jul 1 doi: 10.1097/PAP.0000000000000351. PMID: 35778792
Childhood ovarian nonseminomatous germ cell tumors: A highly curable disease with few long-term treatment-related toxicities-Results of the French TGM95 study.
Pavone R, Pacquement H, Pasquet M, Sudour-Bonnange H, Hameury F, Sarnacki S, Chastagner P, Faure-Conter C, Poirée M, Taque S, Patte C, Fresneau B
Int J Cancer 2021 Nov 1;149(9):1705-1712. Epub 2021 Jul 5 doi: 10.1002/ijc.33710. PMID: 34146403
First evidence of genotype-phenotype correlations in Gorlin syndrome.
Evans DG, Oudit D, Smith MJ, Rutkowski D, Allan E, Newman WG, Lear JT
J Med Genet 2017 Aug;54(8):530-536. Epub 2017 Jun 8 doi: 10.1136/jmedgenet-2017-104669. PMID: 28596197

Supplemental Content

Table of contents

    Practice guidelines

    • PubMed
      See practice and clinical guidelines in PubMed. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.
    • Bookshelf
      See practice and clinical guidelines in NCBI Bookshelf. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.

    Related information

    • PubMed
      Related literature resources in PubMed

    Recent activity

    Clear Turn Off Turn On

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...